Breaking News
December 12, 2018 - Sacrificial immune cells alert body to infection
December 12, 2018 - Low-salt diet may be more beneficial for females than males
December 12, 2018 - Major soil organic matter compound battles chronic wasting disease
December 12, 2018 - Findings may open up new ways to treat dwarfism and other ER-stress-related conditions
December 12, 2018 - New computational model provides clearer picture of shape-changing cells’ structure and mechanics
December 12, 2018 - 10 Facts on Patient Safety
December 12, 2018 - Poorest dying nearly 10 years younger than the rich in ‘deeply worrying’ trend for UK
December 12, 2018 - Innovative care model for children with ASD reduces use of behavioral drugs in ED
December 12, 2018 - Spending time in and around Hong Kong’s waters linked to better health and wellbeing
December 12, 2018 - Simple measures to prevent weight gain over Christmas
December 12, 2018 - Research advances offer hope for patient-tailored AML treatment
December 12, 2018 - Researchers discover a ‘blind spot’ in atomic force microscopy
December 12, 2018 - Sprayable gel could help prevent recurrences of cancer after surgery
December 12, 2018 - SLU researchers explore how fetal exposure to inflammation can alter immunity in newborns
December 12, 2018 - How do patients want to discuss symptoms with clinicians?
December 12, 2018 - Zinc chelation may be able to deliver drug to insulin-producing cells
December 12, 2018 - Brigham researchers develop automated, low-cost tool to predict a woman’s ovulation
December 12, 2018 - Some people with Type 2 diabetes may be testing their blood sugar more often than needed
December 12, 2018 - Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study
December 12, 2018 - Study provides new information regarding microRNA function in cellular homeostasis of zebrafish
December 12, 2018 - Study provides new understanding of mysterious ‘hereditary swelling’
December 12, 2018 - Researchers shed new light on how to combat Shiga and ricin toxins
December 12, 2018 - Pregnant Women Commonly Refuse Vaccines
December 12, 2018 - Drug treatment could offer new hope for some patients with brain bleeding
December 12, 2018 - Health care financial burden of animal-related injuries is growing, study says
December 12, 2018 - Macrophage cells could help repair the heart following a heart attack, study finds
December 12, 2018 - Researchers develop new system for efficiently producing human norovirus
December 12, 2018 - New artificial intelligence-based system to differentiate between different types of cancer cells
December 11, 2018 - Brazilian professors propose guidelines for therapeutic use of melatonin
December 11, 2018 - Healthy Lifestyle Lowers Odds of Breast Cancer’s Return
December 11, 2018 - New research identifies two genes linked to serious congenital heart condition
December 11, 2018 - NIH Director talks science, STEM careers with preteens
December 11, 2018 - Disabling a Cellular Antivirus System Could Improve Gene Therapy
December 11, 2018 - New tool swiftly provides accurate measure of patients’ cognitive difficulties
December 11, 2018 - NICE releases new guidelines for diagnosis and management of COPD
December 11, 2018 - Without Obamacare penalty, think it’ll be nice to drop your plan? Better think twice
December 11, 2018 - Researchers capture high-resolution X-ray and NMR image of key immune regulator
December 11, 2018 - Natural flavonoid is effective at treating leishmanisis infections, study shows
December 11, 2018 - Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows
December 11, 2018 - Study identifies how hantaviruses infect lung cells
December 11, 2018 - Improving PTSD care through genetics
December 11, 2018 - Dermatology providers show interest in recommending cannabinoids to patients
December 11, 2018 - Researchers to study effects of electroconvulsive therapy on Alzheimer’s patients with aggression
December 11, 2018 - Four dried fruits have lower glycemic index than starchy foods, study finds
December 11, 2018 - Optimization of drug dose sizes can reduce pharmaceutical wastage
December 11, 2018 - Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed
December 11, 2018 - PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds
December 11, 2018 - Researchers aim to identify and target high blood pressure indicators
December 11, 2018 - Researchers identify immune cell subset that may drive chronic inflammation
December 11, 2018 - Ezogabine treatment reduces motor neuron excitability in ALS patients, study shows
December 11, 2018 - One implant, two prices. It depends on who’s paying.
December 11, 2018 - Standardizing feeding practices improves growth trends for micro-preemies
December 11, 2018 - COPD Tied to Obesity in Male, Female Never-Smokers
December 11, 2018 - Flossing: Information for Caregivers
December 11, 2018 - Does breastfeeding hormone protect against type 2 diabetes?
December 11, 2018 - Educating future doctors to prescribe physical activity for their patients
December 11, 2018 - Krystal 2000 microplate design improves fluorescence and luminescence measurement
December 11, 2018 - FDA clears mobile medical app to help increase retention in recovery program for opioid use disorder
December 11, 2018 - Overcoming Challenges in High-Speed Centrifugation Experiments
December 11, 2018 - Study shows link between neighborhoods’ socioeconomic status and dietary choices
December 11, 2018 - Lower BMI before obesity surgery predicts greater post-operative weight loss, study finds
December 11, 2018 - Obesity May Be Driving Rise in Uterine Cancers
December 11, 2018 - Antioxidants may prevent cognitive impairment in diabetes
December 11, 2018 - Study discovers link between meditation and how individuals respond to feedback
December 11, 2018 - Researchers identify potential diagnostic tool for Alzheimer’s disease
December 11, 2018 - Oral cancer prognostic signature identified
December 11, 2018 - How Can I Find Out What Caused My Miscarriage?
December 11, 2018 - Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed
December 11, 2018 - Study uncovers 11 new genes associated with epilepsy
December 11, 2018 - Filling research gaps could help develop more disability-inclusive workplaces
December 11, 2018 - Cartilage tissue engineering brings good news for patients with cartilage defects
December 11, 2018 - Novel 3D printing workflow helps predict leaky heart valves
December 11, 2018 - Imagination can help overcome fear and anxiety-related disorders, shows study
December 11, 2018 - Are caries linked to political regime?
December 11, 2018 - Leader in Diabetes Clinical Trials Wins Naomi Berrie Award
December 11, 2018 - Scientists discover cellular mechanism that triggers pneumonia in humans
December 11, 2018 - Increasing mental health problems related to drug use in over 55’s
December 11, 2018 - High-intensity interval exercise could help combat cognitive dysfunction in obese people
December 11, 2018 - Annual flu shot can save lives of heart failure patients
December 11, 2018 - Researchers compare health outcomes for VA and non-VA hospitals
FGF-18 Drug Builds Knee Cartilage in Osteoarthritis

FGF-18 Drug Builds Knee Cartilage in Osteoarthritis

image_pdfDownload PDFimage_print

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.

SAN DIEGO — Intra-articular injections of a protein drug derived from fibroblast growth factor-18 in patients with knee osteoarthritis (OA) led to increases in mean cartilage thickness within the joint after two years, although no significant change in symptom scores was seen, a researcher said here.

At the highest dose of the drug, called sprifermin, mean total MRI-measured cartilage thickness in the knee joint increased by 0.03 mm at the year 2 evaluation, whereas patients receiving placebo injections had a loss of 0.02 mm in cartilage thickness, said Marc Hochberg, MD, of the University of Maryland School of Medicine in Baltimore.

Other radiologic measures of joint structure also showed a significant benefit for sprifermin at the higher dose, Hochberg said at a late-breaking session at the American College of Rheumatology annual meeting. But the same downward trajectory was seen in scores on the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) scale for all treatment groups including placebo.

Hochberg noted that the phase II study is planned to extend for 5 years, and said the investigators still hold out hope that clinical symptoms will improve with sprifermin in these later years. He also pointed out that patients were permitted to take pain medications during the study, which could have masked clinical effects from the drug during this initial portion of the study.

In the trial, approximately 550 patients were randomized to receive placebo or one of four doses of sprifermin, in injections given three times over a week, repeated every 6 months through month 18. Sprifermin dosing groups were 30 mcg per cycle every 12 months; 30 mcg per cycle every 6 months; 100 mcg per cycle every 12 months; or 100 mcg per cycle every 6 months. To maintain blinding, the 12-month sprifermin groups received placebo injections at months 6 and 18.

Median patient age was about 65, and 70% were female. OA was graded at Kellgren-Lawrence level 2 in roughly 70%; the rest were at grade 3. Mean WOMAC score at baseline was about 40.

At the end of year 2, WOMAC scores declined by 18 to 22 points in all groups, with no significant differences or any trends worth noting.

However, the trial technically succeeded because its prespecified primary endpoint was change in total knee joint cartilage thickness, and all secondary endpoints except for WOMAC score were also radiologic assessments of cartilage thickness and joint space width.

On those measures, the two higher sprifermin doses did very well (Results with the 30-mcg doses, whether patients received two or four cycles, did not differ markedly from placebo).

Highly significant differences from the placebo group were seen in the two 100-mcg dosing groups for MRI-measured medial and lateral tibiofemoral cartilage thickness, both overall and in the central subregions of these cartilage compartments. Medial and lateral minimum joint space width, as measured by x-ray, also significantly favored the high-dose sprifermin groups.

The high-dose groups did experience higher rates of acute inflammatory responses: 22% and 23% for those receiving four and two cycles of 100 mcg, respectively, compared with 13.5% for placebo. All of these occurred in the first cycle, Hochberg said, and none led to study dropout. In all other respects, rates of adverse events of various kinds were the same in all groups, he reported.

Sprifermin’s developer, Merck KGaA of Darmstadt, Germany, said it was “highly encouraged” by the study results, but stopped short of promising a phase III trial.

The study was sponsored by Merck KGaA. Co-authors included employees of EMD Serono, a unit of Merck KGaA.

Hochberg disclosed relevant relationships with Bioiberica, Bristol Myers-Squibb, EMD Serono, Galapagos, IBSA, Eli Lilly, Novartis, Pfizer, Plexxikon, Samumed, Theralogix, and TissueGene.

2017-11-09T09:30:00-0500

Tagged with:

About author

Related Articles